In total agreement lotta. Geert's purchase, though modest, a sign to shareholders that things are on track IMO. The buying will come....................GLTA
All valid points hanna, although I think unlikely Frost, who is in his eighties, needs tiny RXI added to his plate. With a similar situation, albeit large scale, with Opko, and chairman of Teva, my bet he's letting Cauwenbergh run with the ball to see if he is able to come through on a $16mm investment in his company. He's a multi $B aire.
Only solid p2 results will lessen the risk now. There is no immediate need for investors to buy, as why not wait out two or three more months, even at the risk of $1-$2 in pps.
As far as the possibility of being a "loser company", there is certainly that possibility. But then again, what is the attraction to investing in early biotech anyway?
BTW, I bought more shares today....................GLTA
Weak retail holders selling at their stops. Such light volume not indicative of selling off in any way. Remember this stock moves fast even on light volume float such as it is.
Low pps creates fear creates more selling. But is is low volume skiddish holders. "Where are the buyers?" was asked by some posters today. There is no rush to buy this stock now. Whoever is interested in taking a position will watch and wait. I would.
The discomfort now that many share is to ride it out until further company developments. BTW I feel sure that MM's have been playing a leading role in the stock's recent fall. This is not a place for the impatient....GLTA
Exactly so hanna. Do you expect any effort on the part of large holders in attempt to raise pps so as to access LPC funds?............GLTA
No problem saba. As for avi, I dislike stock bashers and I hate what they do. I'll expose the criminals every chance I get. My bet, were on the same page...........GL
Stock bashing.......A stock basher spreads rumors about a security to push the trading price down. Bashers may act on their own account or represent third parties, and may engage in a coordinated attack with a group of people to make their claims seem more legitimate. Post by a certain Avi.morax can be seen on multiple message boards many times each and every day. Individuals suggesting that a company might be headed for trouble might not attract attention, but multiple rumors appearing to originate from different sources are apt to be taken more seriously. Environments like Internet message boards can be particularly fertile ground for stock bashers.
This activity may be illegal under laws governing activities on the stock market, depending on regulations. They could be considered a form of securities fraud if bashers operate with the goal to drive prices down to damage a company or create an opportunity for investors. People acting in concert with the stock basher could be engaging in what is known as a poop and scoop scheme. First, people make negative comments to lower stock prices, and then they buy the stocks as they hit bottom, selling them once the values rise again.
google Sec.gov, RXII, 8K from 4/23/14, first page, also def. of price floor at exhibit 10.1...........GL
I've got to hand it to you avi. You do work hard. I could have used guys like you in my own company. Unfortunately we don't hire criminals, liars, or cheats................Too bad.
As grab mentioned. Meaning in order to access the credit line of $18mm over the next 24 months or so left on the 30 month commitment, shares must be selling above that floor price. Could this have a connection to the preferred selling and thus increasing liquidity in attempt to eventually get the stock trading at higher levels in the near term?
Would it not be in the interest of the large holders, namely Frost, Tang, and Advanced to assist in getting the pps at that level if only to allow access to those funds? Seems to me it would be worth an effort by them to do so. What I do not know is how any of these players are able to achieve same.
I may be thinking too far outside the box here, but a strong possibility exists that RXI's stock has taken the course that it has this past two months or so due to a strategy concerning the above.
Just a thought this afternoon for what it's worth.............GLTA
$18mm non diluting waiting with LPC credit line. Let's see if the powers to be can boost the pps in order to access it.......My guess, its in the works. Hope I'm right....GLTA
yes, found it the contract. Interesting that it also mentions that LPC, its agents, etc. etc, shall not effect any short selling of the stock. Makes one suspect a possible effort on LPC's behalf to buy time by doing just that.
On the other hand, Tang and Frost certainly have the capabilities to offset any such effort, IMHO, based upon their sizable positions and the advantage of capitalizing on financing from LPC.
Just a thought....................GLTA
Where is it stated that the floor price is set at $4.00. It is my understanding the it is set as the lowest price that the seller is willing to accept based on certain factors ie, stock split, recap, reorganization etc.
I will try to find out how the floor price is defined the the LPC agreement. I'm fairly certain that $4 is not a set floor price. .................GLTA
Hanna, I might suggest you send your ideas directly to Dr.C c/o IR. He is a capable CFO according to his past accomplishments. One would think that with the connections between him, Frost, Tang, and whoever else, RXI would have no trouble raising funds privately if in fact their, to quote you; "promising and powerful products" have the potential to warrant it. I,m hopeful that we'll hear more on this issue before long.....................GLTA
And if and when conditions are met, LPC is to make payments upon RXI's demand and receive shares based on the current market price. I could find no mention that RXI's share price must be above $4 in order for them to access LPC's credit commitment. Pls correct me if I am mistaken. As it reads:
Under the terms of the Purchase Agreement, upon execution LPC purchased 500,000 shares of common stock at $4.00 per share, a premium of 7.5% based on the closing price of April 21, 2014, for an initial investment of $2 million. Concurrent with the execution, the Company issued to LPC 100,000 shares of our common stock as a commitment fee. Upon the filing of the first investigational drug application for an ophthalmologic project with the U.S. Food and Drug Administration, LPC will make an additional $1 million share purchase at prevailing market prices of the Company's common stock. In addition, at the sole discretion of the Company, we may sell up to $17 million worth of common stock to LPC over the 30-month term of the Purchase Agreement.
"Prevailing market price" Under the terms of the Purchase Agreement, upon execution LPC purchased 500,000 shares of common stock at $4.00 per share, a premium of 7.5% based on the closing price of April 21, 2014, for an initial investment of $2 million. Concurrent with the execution, the Company issued to LPC 100,000 shares of our common stock as a commitment fee. Upon the filing of the first investigational drug application for an ophthalmologic project with the U.S. Food and Drug Administration, LPC will make an additional $1 million share purchase at prevailing market prices of the Company's common stock. In addition, at the sole discretion of the Company, we may sell up to $17 million worth of common stock to LPC over the 30-month term of the Purchase Agreement.
Lest not forget bio, LPC is committed to $20mm over 30 months. Perhaps 25 months now. Don't underestimate the business acumen of Dr. Cauwenbergh.
Does that about say it all............?